Go to GoReading for breaking news, videos, and the latest top stories in world news, business, politics, health and pop culture.

Should I take Imovane / Zopiclone for insomnia?

101 12
Imovane (Zopiclone)

Other brand names: Alchera, Imozop, Imrest, Limovan, Nocturno,Relaxon, Rhovane, Somnol,Xetix, Ximovan, Z-Dorm, Zopicon, Zimovane, Zileze, Zimoclone, Zopitan, Zorclone, Zopivane, Zopiclon, Zalepla, Zopimed

What does it do, and how do I take it?

Imovane (Zopiclone) is a used as a short-term treatment for patients with difficulties sleeping, including those with insomnia and nocturnal awakening/early awakening. Once taken, it allows the patient to fall asleep quicker, and remain asleep for longer. It can also sometimes also be prescribed by your doctor to treat psychiatric disturbances. It is a cyclopyrrolone which works by releasing gamma amino butyric acid, inducing sleepiness.

Typical dosage is between 7.5mg and 15mg, and 3.75mg (half a 7.5mg tablet) for elderly patients, taken 15-30 minutes before getting into bed. The correct dosage for children has not been established, so if it has been prescribed for a child it should always be taken strictly as instructed.

When you stop taking Imovane (Zopiclone), decrease your dosage gradually. Never abruptly stop taking it, as doing so will increase your chances of experiencing potentially serious withdrawal symptoms.

What side effects might I experience?

If you experience any side effects whilst taking Imovane (Zopiclone) always inform your doctor. If the side effect is worrying or persistent, contact your doctor as soon as you are able to. Possible side effects include drowsiness the following morning/day, headaches, confusion, anxiety, loss of memory, dry Mouth, allergies to ingredients (hypersensitivity), nightmares, diarrhea, constipation, nausea, vomiting, abdominal pain, urticaria, tingling, impotence, or ejaculation failure.

What warning and precautions should I be aware of?

When you have taken Imovane (Zopiclone) it is important to avoid driving, operating dangerous machinery, or participating in any activity requiring a high level of concentration until you know exactly how your body reacts to the medication. If you experience side effects such as drowsiness, dizziness, or confusion when you take this medication, you should avoid these activities completely.

Patients taking Imovane (Zopiclone) risk forming a dependency. As a result, it should normally not be used for more than 4 weeks consecutively at a time. When you stop taking this medicine it is important to do so gradually, and not abruptly, to help prevent withdrawal symptoms and decrease the risk of dependence. If you have any history of alcohol or drug abuse, you should discuss with your doctor whether it is safe for you to use.

Avoid all alcohol consumption within 24 hours before or after taking this medicine.

Imovane (Zopiclone) is not recommended for women who are pregnant or trying to conceive a child. It also should not be taken when breastfeeding.

Avoid Imovane (Zopiclone) if you have had a stroke, severe liver problems, or severe lung problems.

If you are suffering from depression or similar conditions, always discuss the possible implications of taking this medication with your doctor before you start taking it.

Whilst taking Imovane (Zopiclone), avoid taking any sedatives, antidepressants, antipsychotics, skeletal muscle relaxants, antihistamines, narcotic analgesics, anaesthetics, neuroleptics, anxiolytics, antiepileptics, non-selective MAO inhibitors, phenothiazines, imipramine.

Always inform your doctor of any allergies you have, and any other medication you are taking or have taken recently (including both non-prescriptions medication and herbal or dietary supplements).

Conclusion

Imovane / Zopiclone has many disadvantages, however can still be useful and normally relatively safe as a short-term insomnia fix. It is never the answer long term!

http://www.ezchemist.co.uk

http://ezchemist.co.uk/ez/imovane-zopiclone-7-5mg-10-tablets-2/
Source...

Leave A Reply

Your email address will not be published.